Magnera Corp
NYSE:MAGN

Watchlist Manager
Magnera Corp Logo
Magnera Corp
NYSE:MAGN
Watchlist
Price: 9.07 USD -2.99% Market Closed
Market Cap: $325.6m

Magnera Corp
Investor Relations

Magnera Corp is a US-based company operating in Paper & Forest Products industry. The company is headquartered in Charlotte, North Carolina and currently employs 2,867 full-time employees. Magnera Corporation, formerly Glatfelter Corporation, is a specialty materials and nonwovens company. The company provides a platform of solutions for the specialty materials industry. The company offers a range of products, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. The company has a diverse business and customer mix, with a platform of over 46 global manufacturing facilities across a portfolio of products and solutions, including adult incontinence, baby care, feminine hygiene, food and beverage, home and healthcare, infrastructure and wipes. Its nonwoven solutions include Spunmelt, Airlaid, Wetlaid, Spunlace, Spinlace, Meltblown, Adhesive bond, needlepunch, and Through Air Bonded. Its Films & Laminates include Breathable Film, Elastic Film, Cast film, and Blown Film. Its brands include Typar, Chicopee, Sontara, Terram, Fabrene, Tubex, and Geca Tapes.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Feb 5, 2026
AI Summary
Q1 2026

Revenue: Quarterly sales were $792 million, with strength in consumer solutions offset by weakness in Latin America and Europe.

Earnings: Adjusted EBITDA was $93 million, flat year-over-year, and in line with expectations.

Guidance: Management reaffirmed guidance for 9% EBITDA growth in 2026, driven by synergy realization and Project CORE cost initiatives.

Segment Performance: Americas saw 2% organic volume growth, while Rest of World EBITDA rose 9% despite revenue declines.

Innovation: Product innovation, especially in healthcare and advanced materials, is expected to support margins and growth.

South America: Portfolio is shifting from baby to adult incontinence products, with adult now 20% of the segment and expected to grow.

Cash Flow & Debt: Free cash flow over the last year was $97 million; $27 million of debt was repaid in the quarter, targeting $100 million for the year.

Macro Environment: North America shows growth, Europe remains soft, and South America is stabilizing amid competitive pressures.

Key Financials
Revenue
$792 million
Adjusted EBITDA
$93 million
Free Cash Flow (TTM)
$97 million
Available Liquidity
$550 million
Debt Repayment (Quarter)
$27 million
Americas Organic Volume Growth
2%
Rest of World Adjusted EBITDA
$35 million
Adult Incontinence Share (South America)
20% of South American portfolio
Other Earnings Calls

Management

Mr. Curtis L. Begle
CEO, President & Director
No Bio Available
Mr. James M. Till
Executive VP, CFO & Treasurer
No Bio Available
Mr. Tarun Manroa
Executive VP & COO
No Bio Available
Mr. Phil Lerro
Chief Information Officer
No Bio Available
Ms. Eileen L. Beck
Chief Human Resources Officers and Executive VP of Human Resources & Administration
No Bio Available
Robert Weilminster
Executive Vice President of Strategy, Integration, Corporate Development & Investor Relations
No Bio Available
Ms. Jill L. Urey
Executive VP, General Counsel & Corporate Secretary
No Bio Available
Mr. Paul Harmon
Chief Innovation & Marketing Officer
No Bio Available
Mr. Achim Schalk
President of EMEIA & APAC
No Bio Available
Mr. David Parks
President of Americas
No Bio Available

Contacts

Address
NORTH CAROLINA
Charlotte
9335 Harris Corners Pkwy, Suite 300
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett